ZOETIS INC (1ZTS.MI) Fundamental Analysis & Valuation

BIT:1ZTS • US98978V1035

Current stock price

109.66 EUR
+3.02 (+2.83%)
Last:

This 1ZTS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1ZTS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ZTS was profitable.
  • In the past year 1ZTS had a positive cash flow from operations.
  • In the past 5 years 1ZTS has always been profitable.
  • In the past 5 years 1ZTS always reported a positive cash flow from operatings.
1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCF1ZTS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of 1ZTS (17.49%) is better than 92.59% of its industry peers.
  • 1ZTS has a better Return On Equity (49.11%) than 90.74% of its industry peers.
  • The Return On Invested Capital of 1ZTS (21.45%) is better than 85.19% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ZTS is significantly above the industry average of 14.78%.
Industry RankSector Rank
ROA 17.49%
ROE 49.11%
ROIC 21.45%
ROA(3y)16.01%
ROA(5y)14.94%
ROE(3y)49.01%
ROE(5y)47.06%
ROIC(3y)21.64%
ROIC(5y)19.86%
1ZTS.MI Yearly ROA, ROE, ROIC1ZTS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • 1ZTS has a better Profit Margin (28.21%) than 87.04% of its industry peers.
  • 1ZTS's Profit Margin has improved in the last couple of years.
  • 1ZTS's Operating Margin of 38.25% is amongst the best of the industry. 1ZTS outperforms 90.74% of its industry peers.
  • 1ZTS's Operating Margin has improved in the last couple of years.
  • 1ZTS has a Gross Margin (71.71%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of 1ZTS has remained more or less at the same level.
Industry RankSector Rank
OM 38.25%
PM (TTM) 28.21%
GM 71.71%
OM growth 3Y0.39%
OM growth 5Y2.44%
PM growth 3Y0.84%
PM growth 5Y2.31%
GM growth 3Y0.03%
GM growth 5Y0.65%
1ZTS.MI Yearly Profit, Operating, Gross Margins1ZTS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1ZTS.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1ZTS is creating value.
  • Compared to 1 year ago, 1ZTS has less shares outstanding
  • 1ZTS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1ZTS has a worse debt to assets ratio.
1ZTS.MI Yearly Shares Outstanding1ZTS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
1ZTS.MI Yearly Total Debt VS Total Assets1ZTS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • 1ZTS has an Altman-Z score of 6.47. This indicates that 1ZTS is financially healthy and has little risk of bankruptcy at the moment.
  • 1ZTS has a better Altman-Z score (6.47) than 88.89% of its industry peers.
  • The Debt to FCF ratio of 1ZTS is 3.16, which is a good value as it means it would take 1ZTS, 3.16 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1ZTS (3.16) is better than 68.52% of its industry peers.
  • 1ZTS has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • 1ZTS's Debt to Equity ratio of 1.31 is on the low side compared to the rest of the industry. 1ZTS is outperformed by 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.16
Altman-Z 6.47
ROIC/WACC2.32
WACC9.25%
1ZTS.MI Yearly LT Debt VS Equity VS FCF1ZTS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • 1ZTS has a Current Ratio of 3.64. This indicates that 1ZTS is financially healthy and has no problem in meeting its short term obligations.
  • 1ZTS's Current ratio of 3.64 is amongst the best of the industry. 1ZTS outperforms 92.59% of its industry peers.
  • 1ZTS has a Quick Ratio of 2.28. This indicates that 1ZTS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 1ZTS (2.28) is better than 87.04% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 2.28
1ZTS.MI Yearly Current Assets VS Current Liabilites1ZTS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ZTS.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.07% over the past year.
  • 1ZTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.22% yearly.
  • The Revenue has been growing slightly by 2.68% in the past year.
  • Measured over the past years, 1ZTS shows a quite strong growth in Revenue. The Revenue has been growing by 8.14% on average per year.
EPS 1Y (TTM)10.07%
EPS 3Y8%
EPS 5Y10.22%
EPS Q2Q%7.59%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y5.98%
Revenue growth 5Y8.14%
Sales Q2Q%0.5%

3.2 Future

  • 1ZTS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.88% yearly.
  • Based on estimates for the next years, 1ZTS will show a small growth in Revenue. The Revenue will grow by 4.67% on average per year.
EPS Next Y8.19%
EPS Next 2Y7.71%
EPS Next 3Y8.12%
EPS Next 5Y7.88%
Revenue Next Year2.07%
Revenue Next 2Y3.52%
Revenue Next 3Y4.18%
Revenue Next 5Y4.67%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1ZTS.MI Yearly Revenue VS Estimates1ZTS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1ZTS.MI Yearly EPS VS Estimates1ZTS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1ZTS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.97, the valuation of 1ZTS can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as 1ZTS.
  • When comparing the Price/Earnings ratio of 1ZTS to the average of the S&P500 Index (25.70), we can say 1ZTS is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 18.44, 1ZTS is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ZTS is on the same level as its industry peers.
  • 1ZTS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 19.97
Fwd PE 18.44
1ZTS.MI Price Earnings VS Forward Price Earnings1ZTS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1ZTS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 1ZTS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.91
EV/EBITDA 14.89
1ZTS.MI Per share data1ZTS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1ZTS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)1.96
EPS Next 2Y7.71%
EPS Next 3Y8.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. 1ZTS.MI Dividend Analysis

5.1 Amount

  • 1ZTS has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • 1ZTS's Dividend Yield is comparable with the industry average which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1ZTS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of 1ZTS grows each year by 20.56%, which is quite nice.
Dividend Growth(5Y)20.56%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 32.55% of the earnings are spent on dividend by 1ZTS. This is a low number and sustainable payout ratio.
  • The dividend of 1ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP32.55%
EPS Next 2Y7.71%
EPS Next 3Y8.12%
1ZTS.MI Yearly Income VS Free CF VS Dividend1ZTS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1ZTS.MI Dividend Payout.1ZTS.MI Dividend Payout, showing the Payout Ratio.1ZTS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ZTS.MI Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

BIT:1ZTS (3/2/2026, 7:00:00 PM)

109.66

+3.02 (+2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners100.79%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap46.29B
Revenue(TTM)9.40B
Net Income(TTM)2.65B
Analysts77.6
Price Target132.47 (20.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.77
Dividend Growth(5Y)20.56%
DP32.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.77%
Min EPS beat(2)3.79%
Max EPS beat(2)7.75%
EPS beat(4)4
Avg EPS beat(4)5.09%
Min EPS beat(4)3.63%
Max EPS beat(4)7.75%
EPS beat(8)7
Avg EPS beat(8)3.39%
EPS beat(12)10
Avg EPS beat(12)3.67%
EPS beat(16)12
Avg EPS beat(16)2.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)1.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.2%
Revenue beat(16)7
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)-9.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 19.97
Fwd PE 18.44
P/S 5.94
P/FCF 24.91
P/OCF 19.14
P/B 10.34
P/tB 35.01
EV/EBITDA 14.89
EPS(TTM)5.49
EY5.01%
EPS(NY)5.95
Fwd EY5.42%
FCF(TTM)4.4
FCFY4.01%
OCF(TTM)5.73
OCFY5.23%
SpS18.47
BVpS10.61
TBVpS3.13
PEG (NY)2.44
PEG (5Y)1.96
Graham Number36.2
Profitability
Industry RankSector Rank
ROA 17.49%
ROE 49.11%
ROCE 26.92%
ROIC 21.45%
ROICexc 25.41%
ROICexgc 38.35%
OM 38.25%
PM (TTM) 28.21%
GM 71.71%
FCFM 23.84%
ROA(3y)16.01%
ROA(5y)14.94%
ROE(3y)49.01%
ROE(5y)47.06%
ROIC(3y)21.64%
ROIC(5y)19.86%
ROICexc(3y)27.73%
ROICexc(5y)26.47%
ROICexgc(3y)50.54%
ROICexgc(5y)50.93%
ROCE(3y)27.16%
ROCE(5y)24.93%
ROICexgc growth 3Y2.53%
ROICexgc growth 5Y2.14%
ROICexc growth 3Y5.51%
ROICexc growth 5Y8.06%
OM growth 3Y0.39%
OM growth 5Y2.44%
PM growth 3Y0.84%
PM growth 5Y2.31%
GM growth 3Y0.03%
GM growth 5Y0.65%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.16
Debt/EBITDA 1.73
Cap/Depr 138.24%
Cap/Sales 7.19%
Interest Coverage 12.22
Cash Conversion 71.42%
Profit Quality 84.5%
Current Ratio 3.64
Quick Ratio 2.28
Altman-Z 6.47
F-Score6
WACC9.25%
ROIC/WACC2.32
Cap/Depr(3y)135.63%
Cap/Depr(5y)123.22%
Cap/Sales(3y)7.63%
Cap/Sales(5y)7.16%
Profit Quality(3y)74.77%
Profit Quality(5y)82.34%
High Growth Momentum
Growth
EPS 1Y (TTM)10.07%
EPS 3Y8%
EPS 5Y10.22%
EPS Q2Q%7.59%
EPS Next Y8.19%
EPS Next 2Y7.71%
EPS Next 3Y8.12%
EPS Next 5Y7.88%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y5.98%
Revenue growth 5Y8.14%
Sales Q2Q%0.5%
Revenue Next Year2.07%
Revenue Next 2Y3.52%
Revenue Next 3Y4.18%
Revenue Next 5Y4.67%
EBIT growth 1Y7.7%
EBIT growth 3Y6.4%
EBIT growth 5Y10.78%
EBIT Next Year16.84%
EBIT Next 3Y9.66%
EBIT Next 5Y7.94%
FCF growth 1Y50.13%
FCF growth 3Y9.8%
FCF growth 5Y11.47%
OCF growth 1Y32.73%
OCF growth 3Y10.09%
OCF growth 5Y10.47%

ZOETIS INC / 1ZTS.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOETIS INC (1ZTS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 3 / 10 to ZOETIS INC (1ZTS.MI). This can be considered as Overvalued.


What is the profitability of 1ZTS stock?

ZOETIS INC (1ZTS.MI) has a profitability rating of 8 / 10.


What is the expected EPS growth for ZOETIS INC (1ZTS.MI) stock?

The Earnings per Share (EPS) of ZOETIS INC (1ZTS.MI) is expected to grow by 8.19% in the next year.


How sustainable is the dividend of ZOETIS INC (1ZTS.MI) stock?

The dividend rating of ZOETIS INC (1ZTS.MI) is 4 / 10 and the dividend payout ratio is 32.55%.